ORYLMYTE 300 IR, sublingual tablet 30 tablets
Active ingredients: EXTRAIT ALLERGÉNIQUE DE DERMATOPHAGOIDES FARINAE, EXTRAIT ALLERGÉNIQUE DE DERMATOPHAGOIDES PTERONYSSINUS
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tabletssublinguale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ORYLMYTE 300 IR, comprimé sublingual
- Pharmaceutical form
- comprimé
- Route of administration
- sublinguale
- Presentation description
- plaquette(s) PVC aluminium OPA : polyamide orienté de 30 comprimé(s)
- Marketing authorisation holder
- STALLERGENES
- Reimbursement according to BDPM
- 15 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Dec 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
68744977CIP73023601CIP133400930236017Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| EXTRAIT ALLERGÉNIQUE DE DERMATOPHAGOIDES PTERONYSSINUScomprimé | 150 IR · un comprimé | SA |
| EXTRAIT ALLERGÉNIQUE DE DERMATOPHAGOIDES FARINAEcomprimé | 150 IR · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.